NIOX Group (LON:NIOX) Issues Quarterly Earnings Results

NIOX Group (LON:NIOX) released its quarterly earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%.

NIOX Group Trading Down 4.3%

NIOX Group stock traded down GBX 3 during mid-day trading on Thursday, hitting GBX 66. The company’s stock had a trading volume of 215,753 shares, compared to its average volume of 799,601. The business has a 50 day moving average price of GBX 65.75 and a 200-day moving average price of GBX 61.67. The company has a debt-to-equity ratio of 1.06, a current ratio of 4.60 and a quick ratio of 1.94. NIOX Group has a 12 month low of GBX 53.84 and a 12 month high of GBX 76. The stock has a market cap of £277.77 million, a price-to-earnings ratio of 40.24 and a beta of 0.92.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.